4//SEC Filing
Dahan Michel 4
Accession 0001562180-23-004168
CIK 0001517022other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:09 PM ET
Size
8.5 KB
Accession
0001562180-23-004168
Insider Transaction Report
Form 4
Dahan Michel
SVP, Chief Business Officer
Transactions
- Award
Common Stock
2023-05-12+200,000→ 469,515 total
Footnotes (1)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001669737
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:09 PM ET
- Size
- 8.5 KB